Q4 2022 Holdings
Filed 2023-02-14 | 33 holdings | $385.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cullinan Oncology, Inc.(CGEM) | Common | 230031106 | $80.7M | 7,648,268 | 20.9% |
| iTeos Therapeutics, Inc.(5E7) | Common | 46565G104 | $34.1M | 1,745,943 | 8.8% |
| Inhibrx, Inc Com(INBXUSD) | Common | 45720L107 | $31.7M | 1,286,435 | 8.2% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $24.1M | 1,639,849 | 6.3% |
| Iveric Bio Inc(OPHTEUR) | Common | 46583P102 | $22.7M | 1,059,688 | 5.9% |
| Uniqure N.V.(QURE) | Common | N90064101 | $21.3M | 939,966 | 5.5% |
| Geron Corporation(GERN) | Common | 374163103 | $20.5M | 8,466,981 | 5.3% |
| Intellia Therapeutics, Inc.(NTLA) | Common | 45826J105 | $15.9M | 455,238 | 4.1% |
| Verve Therapeutics, Inc | Common | 92539P101 | $15.6M | 808,661 | 4.1% |
| Regenxbio Inc.(RGNX) | Common | 75901B107 | $14.1M | 621,372 | 3.7% |
| Iovance Biotherapeutics Inc Com(IOVA) | Common | 462260100 | $13.7M | 2,149,550 | 3.6% |
| Provention Bio Inc(PRVBUSD) | Common | 74374N102 | $9.5M | 898,483 | 2.5% |
| Insmed Incorporated(INSM) | Common | 457669307 | $8.2M | 410,463 | 2.1% |
| Madrigal Pharmaceuticals inc(MDGL) | Common | 558868105 | $7.8M | 26,773 | 2.0% |
| Harmony Biosciences Hldgs Inc.(HRMY) | Common | 413197104 | $7.7M | 139,377 | 2.0% |
| Reata Pharmaceuticals inc(RETAEUR) | Common | 75615P103 | $7.4M | 194,181 | 1.9% |
| Crinetics Pharmaceuticals Inc.(CRNX) | Common | 22663K107 | $6.8M | 371,639 | 1.8% |
| Travere Therapeutics Inc.(TVTX) | Common | 89422G107 | $5.9M | 281,711 | 1.5% |
| Werewolf Therapeutics, Inc.(HOWL) | Common | 95075A107 | $4.9M | 2,388,011 | 1.3% |
| Amicus Therapeutics Inc.(FOLD) | Common | 03152W109 | $4.9M | 400,410 | 1.3% |
| Axsome Therapeutics, Inc.(AXSM) | Common | 05464T104 | $4.0M | 51,975 | 1.0% |
| Arcutis Biotherapeutics inc(ARQT) | Common | 03969K108 | $3.9M | 262,069 | 1.0% |
| Revolution Medicines, Inc.(RVMD) | Common | 76155X100 | $3.6M | 149,043 | 0.9% |
| G1 Therapeutics, Inc.(GTHXEUR) | Common | 3621LQ109 | $3.5M | 650,000 | 0.9% |
| Tcr2 Therapeutics, Inc. | Common | 87808K106 | $3.4M | 3,370,982 | 0.9% |
| Harpoon Therapeutics, Inc. | Common | 41358P106 | $2.3M | 3,196,707 | 0.6% |
| Phathom Pharmaceuticals inc(PHAT) | Common | 71722W107 | $2.2M | 195,942 | 0.6% |
| Chinook Therapeutics, Inc.(290A) | Common | 16961L106 | $2.1M | 80,000 | 0.5% |
| Praxis Precision Medicines Inc. | Common | 74006W108 | $1.5M | 610,000 | 0.4% |
| Oncorus, Inc. | Common | 68236R103 | $601.4K | 2,377,031 | 0.2% |
| Avrobio, Inc. | Common | 05455M100 | $461.9K | 647,918 | 0.1% |
| Black Diamond Therapeutics, Inc.(BDTX) | Common | 09203E105 | $260.8K | 144,888 | 0.1% |
| Inozyme Pharma Inc. | Common | 45790W108 | $242.0K | 230,500 | 0.1% |